Search results
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Motley Fool via Yahoo Finance· 2 months agoSince 2021, shares of Novavax (NASDAQ: NVAX) have absolutely crumbled, falling by a whopping 95%....
This Could Spell Bad News for Novavax
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) investors are likely feeling frustrated. First, they had to wait as the company delayed filing for an Emergency Use Authorization...
Why Investors Yawned at Novavax's Great FDA Panel News
Motley Fool· 2 years agoTuesday was a crucial day for Novavax (NASDAQ: NVAX). At long last, the U.S. Food and Drug...
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...
FDA Committee Proposes EUA Nod to Novavax's (NVAX) COVID Jab
Zacks via Yahoo Finance· 2 years agoAn FDA advisory committee supports granting emergency use authorization to Novavax's (NVAX) COVID-19...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Novavax's Revenue Could Fall Even More -- and It's Actually Good News
Motley Fool· 2 years agoPick your favorite of these adjectives, and it will definitely apply to Novavax's (NASDAQ: NVAX) second-quarter update. What's more, Novavax slashed its full-year revenue guidance. Unsurprisingly ...